Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network
Claire Dupuis, Étienne de Montmollin, Niccolò Buetti, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0255644-e0255644
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19
Charles‐Hervé Vacheron, Alain Lepape, Anne Savey, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 2, pp. 161-169
Open Access | Times Cited: 51
Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set
Andrew Conway Morris, Katharina Köhler, Thomas De Corte, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 44
Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS
Pauline Lamouche-Wilquin, Jérôme Souchard, Morgane Peré, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 28
Ventilator-Associated Pneumonia in COVID-19 Patients Admitted in Intensive Care Units: Relapse, Therapeutic Failure and Attributable Mortality—A Multicentric Observational Study from the OutcomeRea Network
Paul-Henri Wicky, Claire Dupuis, Charles Cerf, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1298-1298
Open Access | Times Cited: 20
COVID-19 Therapeutic Potential of Natural Products
Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9589-9589
Open Access | Times Cited: 19
Risk factors for bloodstream infection in COVID-19 patients in intensive care units: a systematic review and meta-analysis
Jun Wang, Ting Jiang
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Antoní Torres, Ana Motos, Catia Cillóniz, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 7, pp. 850-864
Open Access | Times Cited: 24
Epidemiology, risk factors and prognosis of ventilator-associated pneumonia during severe COVID-19: Multicenter observational study across 149 European Intensive Care Units
Marc Garnier, Jean-Michel Constantin, Nicholas Heming, et al.
Anaesthesia Critical Care & Pain Medicine (2022) Vol. 42, Iss. 1, pp. 101184-101184
Open Access | Times Cited: 22
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Antonio Moreno, Raquel Carbonell, Ignacio Martín‐Loeches, et al.
Annals of Intensive Care (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study
Valentine Lidou-Renault, Édouard Baudouin, Pauline Courtois-Amiot, et al.
The Journals of Gerontology Series A (2022) Vol. 77, Iss. 7, pp. 1352-1360
Open Access | Times Cited: 11
Causal inference using observational intensive care unit data: a scoping review and recommendations for future practice
Jim M. Smit, Jesse H. Krijthe, Wouter M. R. Kant, et al.
npj Digital Medicine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Timing of corticosteroids in non-severe non-hospitalized COVID-19 patients: open-label, two-center, randomized controlled study (TICS-COV19 study)
Emad R. Issak, Mariam Maged Amin
The Korean Journal of Internal Medicine (2023) Vol. 38, Iss. 2, pp. 207-217
Open Access | Times Cited: 5
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Luís Coelho, F Falcão, Pedro Póvoa, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
How common is ventilator-associated pneumonia after coronavirus disease 2019?
Paul-Henri Wicky, Camille d’Humières, Jean‐François Timsit
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 2, pp. 170-175
Open Access | Times Cited: 9
Effect of Early Dexamethasone on Outcomes of COVID-19: A Quasi-experimental Study Using Propensity Score Matching
Wang-Da Liu, Jann‐Tay Wang, Ming-Chieh Shih, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 414-425
Open Access | Times Cited: 1
Antibiotic Usage in the COVID-19 Intensive Care Unit of an Infectious Diseases Hospital from Nord-Eastern Romania
A Vâţă, Florin Roşu, Olivia Dorneanu, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 645-645
Open Access | Times Cited: 4
Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study
Bálint Gergely Szabó, Eszter Czél, I. Nagy, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1196-1196
Open Access | Times Cited: 4
Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza
Guillaume Laurichesse, Carole Schwebel, Niccolò Buetti, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Early Corticosteroid Therapy May Increase Ventilator-Associated Lower Respiratory Tract Infection in Critically Ill Patients with COVID-19: A Multicenter Retrospective Cohort Study
Jean-Baptiste Mesland, Eric Carlier, Bruno François, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 984-984
Open Access | Times Cited: 6
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
Sylvie Chevret, Lila Bouadma, Claire Dupuis, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Critically Ill Patients: A Cluster Analysis According to Baseline Characteristics, Biological Features, and Chest CT Scan on Admission
Kévin Grapin, Romain De Bauchene, Benjamin Bonnet, et al.
Critical Care Medicine (2023) Vol. 52, Iss. 2, pp. e38-e46
Closed Access | Times Cited: 3
Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study
Lakshmi Swaminathan, Scott Kaatz, Heather Chubb, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 2, pp. 887-898
Open Access | Times Cited: 5
Case report: Enhancing prognosis in severe COVID-19 through human herpes virus coinfection treatment strategies
Ye Lu, Cuihong Wang, Yuan Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access
Nigella sativa, Anthemis hyaline and Citrus sinensis extracts reduce SARS-CoV-2 replication by fluctuating Rho GTPase, PI3K-AKT, and MAPK/ERK pathways in HeLa-CEACAM1a cells
Mehmet Bostancıklıoğlu, Mehri İğci, Mustafa Ulaşlı
Gene (2024) Vol. 911, pp. 148366-148366
Closed Access
Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review
Alexandra Beurton, Emma J. Kooistra, Audrey De Jong, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 3, pp. 545-563
Closed Access
Page 1 - Next Page

Scroll to top